FONTEYNE PAUL R. - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for FONTEYNE PAUL R.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-10-13
Sale		2022-10-13
11:03 am		COVETRUS INC.CVETFONTEYNE PAUL R.
Director		13,275$0$00
(Direct)		View
2022-01-06
Purchase		2022-01-10
8:37 pm		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		3,947$19$74,99312,347
(Direct)		View
2021-08-10
Purchase		2021-08-11
4:09 pm		COVETRUS INC.CVETFONTEYNE PAUL R.
Director		5,000$23.24$116,2005,000
(Direct)		View
2020-11-16
Sale		2020-11-17
3:40 pm		AMAG PHARMACEUTICALS INC.AMAGFONTEYNE PAUL R.
Director		14,676$0$00
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2025-06-05
Option Award		2025-06-09
4:12 pm		N/A
2035-06-04		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		25,000$025,000
(Direct)		View
2025-01-01
Option Award		2025-01-03
4:19 pm		N/A
2032-12-31		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		17,466$033,904
(Direct)		View
2024-06-06
Option Award		2024-06-07
4:52 pm		N/A
2034-06-05		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		25,000$025,000
(Direct)		View
2024-01-01
Option Award		2024-01-02
4:13 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		3,341$022,186
(Direct)		View
2024-01-01
Option Award		2024-01-02
4:13 pm		N/A
2030-12-31		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		5,748$59.8622,186
(Direct)		View
2023-06-08
Option Award		2023-06-12
7:34 pm		N/A
2033-06-08		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		16,985$016,985
(Direct)		View
2023-01-01
Option Award		2023-01-04
5:31 pm		N/A
2030-12-31		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		11,308$020,538
(Direct)		View
2022-07-01
Exercise		2022-07-06
4:06 pm		N/A
2022-07-01		COVETRUS INC.CVETFONTEYNE PAUL R.
Director		8,275$013,275
(Direct)		View
2022-06-09
Option Award		2022-06-10
4:05 pm		N/A
2032-06-09		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		19,000$019,000
(Direct)		View
2022-05-11
Option Award		2022-05-13
4:10 pm		N/A
N/A		COVETRUS INC.CVETFONTEYNE PAUL R.
Director		14,638$014,638
(Direct)		View
2022-05-06
Option Award		2022-05-09
4:17 pm		N/A
N/A		GELESIS HOLDINGS INC.GLSFONTEYNE PAUL R.
Director		53,832$053,832
(Direct)		View

Ownership		2022-01-24
4:39 pm		N/A
2027-01-13		GELESIS HOLDINGS INC.GLSFONTEYNE PAUL R.
Director		0$0292,687
(Direct)		View
2022-01-06
Option Award		2022-01-10
8:37 pm		N/A
2032-01-06		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		8,400$012,347
(Direct)		View

Ownership		2022-01-06
5:06 pm		N/A
2031-03-23		Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director		0$081,100
(Direct)		View
2022-01-01
Option Award		2022-01-04
9:28 pm		N/A
2029-12-31		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		12,784$017,784
(Direct)		View
2021-07-01
Option Award		2021-07-06
4:03 pm		N/A
2022-07-01		COVETRUS INC.CVETFONTEYNE PAUL R.
Director		8,275$08,275
(Direct)		View
2021-01-01
Option Award		2021-01-04
7:31 pm		N/A
2030-12-31		Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director		27,600$027,600
(Direct)		View